Neural crest cells are the embryonic progenitors of several adult cell types, including some neurons that contain the neuroactive peptide somatostatin. To begin to understand the control of peptide expression during neuronal ontogeny, we have investigated the development of somatostatin-like immunoreactivity (SLI) in embryonic quail paravertebral sympathetic ganglia in uivo. SLI was identified by immunohistochemistry in paraformaldehyde-fixed cryostat sections from the trunk region of quail embryos. SLI was first observed in the cells of the primary sympathetic trunks at stage 18 (Zacchei, A. M. (1961) Arch. Ital. Anat. Embriol. 66: 36-62), which corresponds to embryonic day 4 (E4). The primary sympathetic trunks are the sites of the initial aggregation of neural crest cells to form the sympathetic ganglia. The SLI in these cells was located in the cytoplasm and was absent from the nucleus. SLI persisted in subsequent developmental stages as formation of the definitive sympathetic ganglia occurred. At stage 23 (E7), when the lumbosacral paravertebral sympathetic ganglia have reached their definitive location, some cells in the ganglia contained SLI, and they were often located adjacent to one another. During the later stages of embryogenesis, sympathetic ganglia can be dissected from the embryo and the SLI content determined by radioimmunoassay. The amount of SLI is several-fold higher in ganglia removed at stage 23-24 (E7-8) than in ganglia removed at stage 26-27 (E9-10) or stage 31-32 (E13-14). This decline in SLI content reflects an absolute decrease per ganglion and is not solely due to the growth of tissue devoid of SLI. Our results indicate that the appearance of SLI is an early event in the development of some sympathetic neurons in viva and that the SLI content of sympathetic ganglia decreases significantly during later stages of embryonic development when other maturational events are occurring in these ganglia.
Several neuroactive peptides, including those identical or closely related to substance P, somatostatin, vasoactive intestinal polypeptide (VIP), and the enkephalins, have been detected in neurons of neural crest origin in several species (HGkfelt et al., 1980) . The embryonic neural crest gives rise to several adult cell types, including the neurons of the sympathetic, parasympathetic, enteric, and most sensory ganglia (Weston, 1970; Noden, 1978; Le Douarin, 1980) . Substance P and somatostatinlike immunoreactivity (SLI) have been demonstrated in some sensory ganglion neurons; substance P, VIP, and the enkephalins in some enteric ganglion neurons; the enkephalins in cells of the adrenal medulla; and SLI and VIP in some sympathetic ganglion neurons (Hijkfelt et al., 1980; Fontaine-Perus et al., 1982) . In several cases these peptides coexist with a nonpeptide neurotransmitter in the same cell (Hijkfelt et al., 1980) . For example, some sympathetic neurons contain both catecholamines and SLI (H6kfelt et al., 1977) .
Although the existence of neuroactive peptides in particular neuron populations is relatively well documented, our knowledge of the control of neuroactive peptide presence during development is limited. In the developing enteric ganglia of the embryonic chicken, the appearance of substance P-, VIP-, and met-enkephalin-like immunoreactivity has been examined by immunocytochemistry (Fontaine-Perus et al., 1981; Saffrey et al., 1982) . All three peptides were first detected at embryonic ,577 days lo-11 . This is a few days after acetylcholine and 5-hydroxytryptamine-containing intrinsic neurons of the gut first appear (Smith et al., 1977 , Epstein et al., 1980 . One interesting finding is that peptide immunoreactive cell bodies are more numerous in the enteric ganglia of embryonic and young chickens than adults. In addition, when gut tissue from ElO-11 embryos is removed from the embryonic environment to an in uivo tissue culture system on a chick chorioallantoic membrane for 10 days, the number of VIP-and substance P-immunoreactive cell bodies is greater than that seen at 21 days of development in the normal animal in uiuo (Fontaine-Perus et al., 1981) . One possible explanation for these results is that the transport of peptides from the cell bodies to terminals increases during development in uiuo. This would reduce the peptide content in the cell bodies and thus decrease the number of peptide-containing cell bodies detectable by immunocytochemistry later in development. Culture of the gut tissue on the chorioallantoic membrane may restrict the growth of cellular processes and terminals, thereby retaining detectable peptide-containing cell bodies. A second, more interesting, possibility is that the actual number of peptidergic neurons is regulated by environmental influences that are supplied by the embryo and which change during development. Growth of the gut tissue on the chorioallantoic membrane would be free of these influences, allowing more peptidergic neurons to be present than are normally seen in uiuo.
Although such environmental cues have not yet been directly identified in embryos, recent work has identified several influences that appear to regulate peptide expression in developmentally older neurons and cells of the adrenal gland. This work may be relevant to an understanding of the control of neuronal peptide content during embryogenesis. One such influence is the development of synaptic activity. When adult rat adrenal glands are denervated, they exhibit large increases in enkephalin-containing peptides (Lewis et al., 1981) . In adult rat superior cervical ganglia in uiuo, substance P content increases when preganglionic fibers are cut or when impulse activity is blocked (Kessler and Black, 1982) . Similarly, substance P and SLI content increase when neonatal rat superior cervical ganglia are grown in uitro, and this increase is prevented by the presence of depolarizing agents (Kessler et al., 1981 (Kessler et al., ,1983a . These observations on the effect of preganglionic activity on the peptide content of the adrenal gland and superior cervical ganglia are consistent with the results on peptidergic cells in avian enteric ganglia, cited above, in a model in which the development of preganglionic innervation and subsequent synaptic activity act to depress peptide expression in the cells which receive innervation.
In addition to the possible role of preganglionic innervation on peptide content, the pattern of postganglionic innervation by sympathetic neurons has been suggested to be relevant to their peptide content (Lundberg et al., 1982) . Other influences not requiring cell contact also have been demonstrated to alter the peptide content of neurons. Medium conditioned by non-neuronal cells has been reported to alter qualitatively the type of peptide contained in populations of sensory neurons in culture (Mudge, 1981) , and nerve growth factor (NGF) can elevate substance P and SLI content in rat dorsal root sensory ganglia in uiuo Black, 1980, 1981; Otten et al., 1980) .
In the present work we have examined the expression of SLI in embryonic quail paravertebral sympathetic ganglia in uiuo. These experiments addressed the questions of when SLI can be detected, in what cell populations it is found, and what quantitative changes occur in SLI content during embryogenesis. These experiments are a first step toward understanding how peptide content is regulated during embryonic development and what functional role such neuroactive peptides may play in development.
Materials and Methods
Embryos. Fertilized Japanese quail eggs (Coturnix coturn&) were purchased from the Nutritional Sciences Department at the University of Connecticut and incubated at 38°C in a humidified forced draft incubator (Humidaire Incubator Co.). The developmental stage of the embryos was determined according to the method of Zacchei (1961) .
Immunohistochemistry. The location of SLI was determined by the indirect immunofluorescence technique on fixed frozen sections. Embryos stage 19 or older were perfused through the heart with 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, and then fixed further by immersion in the same solution for 1 hr. Embryos younger than stage 18 were fixed by immersion only. After fixation, the embryos were transferred to 10% sucrose in 0.1 M phosphate-buffered saline (PBS), pH 7.4, containing 0.05% sodium azide, for 15 to 18 hr followed by 24 hr in 0.1 M PBS containing 20% sucrose. Embryos were then frozen in OCT embedding compound using isopentane (Baker) cooled with liquid nitrogen. Sections 10 pm thick were cut on an Ames cryostat and mounted onto chrome-alum-coated slides. The sections were dried at room temperature and stored at -20°C until processing with antisera.
To initiate the antibody staining, sections were treated for 5 min at room temperature with 0.3% Triton X-100 (Baker) in PBS, pH 7.4, containing 0.05% sodium azide (TBS). The sections were then exposed to 3% normal porcine serum in TBS for 15 min at room temperature, then they were washed three times in TBS. The sections were incubated overnight at either room temperature or 4°C with antisomatostatin serum (Accurate Chemical and Scientific Co.) at a dilution of 1:500 (unless otherwise indicated in the text) in 1% normal porcine serum in TBS. Both temperatures gave the same results. After three washes with TBS, sections were incubated for 30 min at room temperature in a 1:50 dilution of rhodamine conjugated to swine immunoglobulin directed against rabbit IgG (Accurate Chemical and Scientific Co.). The sections were then washed three times in TBS and coverslipped using glycerin/PBS (3:1, v/v). The slides were inspected on a Zeiss standard microscope equipped for viewing rhodamine fluorescence. To determine the specificity of the observed immunofluorescence, control experiments included (a) the use of normal rabbit serum in place of antisomatostatin serum and (b) and the use Vol. 4, No. 2, Feb. 1984 of antisomatostatin serum in the presence of somatostatin 14 (Penninsula). For these latter adsorption experiments, a 1500 dilution of antisomatostatin serum containing 0.2 mg/ml of the protease inhibitor aprotinin (Sigma) was prepared in 1% normal porcine serum in TBS. Somatostatin 14 (Penninsula) was then added to an aliquot of this solution to give a final concentration of 20 nmoles/ml and allowed to pre-incubate for 2 hr at 4°C. Following this pre-incubation the sections were processed for immunocytochemistry as described above for 18 hr at 4°C using either antisomatostatin serum with or without added somatostatin. Sections exposed to either adsorbed serum or normal rabbit serum lacked specific immunoreactivity. Dissection of sympathetic ganglia. To dissect the ganglia the embryos were first removed from the egg and placed on their dorsal surface in a loo-mm Petri dish. The ventral body wall was opened using iridectomy scissors, and the embryos were eviscerated and cleaned of blood with Hanks' balanced salt solution buffered with 15 mM HEPES to pH 7.4 (HBSS-HEPES). Lumbosacral paravertebral sympathetic ganglia were then dissected with tungsten needles, cut into pieces 2.5 mm long, and collected in a microhomogenizer embedded in dry ice.
Radioimmunoassay.
The amount of immunoreactive somatostatin in undiluted and diluted samples of dissected sympathetic ganglia was determined by a well characterized radioimmunoassay (Pate1 and Reichlin, 1978) . Following dissection, ganglia were homogenized in 200 ~1 of 2 N acetic acid, and the homogenate was allowed to stand for 1 hr at 4°C in a siliconized tube. The samples were then centrifuged at 7000 x g and the supernatant removed and lyophilized. The lyophilized sample was stored at -70°C until assay. The acetic acidinsoluble pellet was retained for protein determination by the method of Lowry et al. (1951) . The radioimmunoassay standard curve was generated using somatostatin 14 (Peninsula). Monoiodinated 1-tyrosine somatostatin (New England Nuclear) was the radioactive ligand. The standard curve and the amount of immunoreactive somatostatin in each sample were calculated using a computer-assisted least squares polynomial fit. The sensitivity of the assay was 2 pg of somatostatin 14 per tube, and the antibody (from Dr. M. Root, Eli Lilly) was used at a final dilution of 1:30,000. This antibody showed 97% cross-reactivity with somatostatin 28 (Bachem) and less than 0.01% cross-reactivity with urotensin II, a peptide with some structural homology to somatostatin.
Results

Immunocytochemistry.
Immunocytochemistry was used to determine when SLI can first be detected in the trunk region of quail embryos, since lumbosacral paravertebral ganglia cannot be dissected for radioimmunoassay analysis much prior to stage 23. SLI was absent from the trunk region of stage 14 (E21/2) and 17 (E3X) embryos, even when the primary antiserum was used at a dilution of 1:lOO. However, SLI was detectable at stage 18 (E4) using a 1:500 dilution of the primary antiserum. In these embryos, the SLI was observed in the primary sympathetic trunks on either side of the dorsal aorta (Fig. 1) . The SLI was seen in the cytoplasm and was absent from the nucleus. The primary sympathetic trunks are the initial sites of condensation of neural crest cells into sympathetic ganglia. Subsequently, some of the cells of the primary sympathetic trunk migrate dorsally to form the definitive paravertebral sympathetic ganglia. By stage 19 (E4Yz) the intensity of the immunofluorescence in the sympathetic trunks had increased, and some individual cells with SLI were seen near to, but displaced from, the main primary sympathetic trunks (Fig. 2A) . These cells may have been migrating dorsally toward the definitive location of the sympathetic ganglia. The SLI was absent if the primary antiserum was pre-incubated in the presence of somatostatin 14 (Fig. 2B) . At stage 19 the morphology of the immunoreactive cells is similar to that seen at stage 18, with immunoreactivity present in the cytoplasm and absent from the nucleus (Fig. 2C) . In stage 23 (E7) embryos a subpopulation of cells in the paravertebral sympathetic ganglia showed SLI, while many cells contained no detectable SLI (Fig. 3, A and B). The SLI was located in cells that were adjacent t,o one another and that often occupied the ventral portion of the ganglion. At stage 27 (ElO) SLI could still be detected in some cells in the ganglia, although the intensity of the immunofluorescence was diminished compared to stage 23 (E7) (Fig. 4, A and B) .
Radioimmunoassay.
When radioimmunoassay was used to quantitate the amount of SLI present in sympathetic ganglia, we found that a substantial amount of SLI was present in ganglia removed at stage 23-24 (E7-8) (Fig. 5) . The SLI content of the ganglia removed at stage 23-24 (E7-8) was much higher than that of ganglia removed at stage 26-27 (E9-10) or stage 31-32 (E13-14) (Fig. 5) . The reduction in SLI content with development was 90% when the data were calculated on a per milligram of protein basis and 75% when they were calculated on a per ganglion basis (Fig. 5) .
Discussion
Our results demonstrate that expression of SLI is an early event in the development of some cells in quail lumbosacral paravertebral sympathetic ganglia. SLI can be detected shortly after the first rudiments of the sympathetic ganglion form. In addition, there is a substantial decrease in SLI content during later stages of development at which other key maturational changes are occurring in these sympathetic ganglia.
Early sympathetic ganglion development and the appearance of SLI. Neural crest cells initially form on the dorsal portion of the neural tube and subsequently migrate along specific pathways in the embryo (Weston, 1970; Noden, 1978; Le Douarin, 1980) . In the trunk region of the embryo there are two major migratory paths. One is a lateral path, below the ectoderm, and the other is a ventral path which is initially adjacent to the neural tube. Some of the neural crest cells which take the ventral path are the progenitors of the sympathetic ganglia (Weston, 1963; Le Douarin and Teillet, 1974; Thiery et al., 1982) . The cells which give rise to the sympathetic ganglia first aggregate at E3Y-E4 to form a structure known as the primary sympathetic trunk (Kuntz, 1910) . This structure is located lateral to the dorsal aorta. Expression of noradrenergic traits, including catecholamine content and immunoreactivity to synthetic enzymes in the catecholamine pathway, occurs shortly after neural crest cells reach this initial site of ganglion formation (Enemar et al., 1965; Kirby and Gilmore, 1976; Allan and Newgreen, 1977; Cochard et al., 1978; Teitelman et al., 1979) . Catecholamine synthesis is probably not a postmitotic event in these cells, since DNA synthesis can be detected in cells that contain catecholamines and the catecholamine synthetic enzyme tyrosine hydroxylase (Cohen, 1974; Rothman et al., 1978 Rothman et al., , 1980 .
We first detected SLI in the sympathetic trunk at stage 18 (E4), just after the stage at which catecholamines first appear. Thus, the onset of SLI in the lumbosacral sympathetic trunk is not any later than stage 18 (E4). Although we could not detect SLI prior to stage 18, it is possible that some SLI is present but that the amount is below the threshold of detection of immunocytochemistry. Like catecholamine-containing cells, SLI-containing cells appear as small clusters of cells with a bilateral distribution lateral to the dorsal aorta (Fig. 1 , Enemar et al., 1965; Kirby and Gilmore, 1976) . Several groups have reported that such cell types as notochord and somitic mesenchyme and the molecule fibronectin, which are found in the vicinity of the developing sympathetic ganglia, can potentiate the expression of adrenergic traits in vitro (Cohen, 1972; Norr, 1973; Teillet et al., 1978; Fauquet et al., 1981; Sieber-Blum et al., 1981; Loring et al., 1982) . The temporal and spatial proximity of SLI and catecholamine appearance in very young sympathetic ganglia raises the possibility that some of the same environmental cues may affect the regulation of both traits. Our present observations do not allow us to conclude that both catecholamines and SLI occur in the same cells in vivo. However, in tissue culture, some quail neural crest cells can develop and contain both catecholamines and SLI . In addition, the coexistence of the catecholamine synthetic enzyme dopamine /3-hydroxylase and SLI has been dem- Figure 2 . SLI in a stage 19 (E4%) embryo. A, Photographic montage using rhodamine optics of the dorsal region of a cryostat section from the trunk region of a stage 19 quail embryo processed to reveal SLI as described under "Materials and Methods." SLI is seen in the primary sympathetic trunks (ST) with some SLI-positive cells in a more dorsal position evident (arrows). For purposes of orientation, the neural tube (NT), notochord (No), dorsal root sensory ganglion (DRG), dorsal aorta (DA), and dorsoventral axis (DV) are labeled. Scale bar, 50 lrn. B, Adsorption control for SLI. Photograph taken with rhodamine optics of a cryostat section adjacent to the one shown in A that was processed with antisomatostatin serum that had been pre-incubated in somatostatin-14 prior to its application to the section as described under "Materials and Methods." No SLI is observed. The notochord (No) and dorsal aorta (DA) are labeled for orientation. Scale bar, 50 pm. C, SLI-containing cells. Higher power photograph using rhodamine optics of SLI-containing cells in the primary sympathetic trunk of a stage 19 embryo. Scale bar, 20 pm. Vol. 4, No. 2, Feb. 1984 Figure 2 stage field onstrated in some sympathetic neurons in vivo in the adult rat and guinea pig (Hokfelt et al., 1977) .
Later sympathetic ganglion development and modulation of SLI content. Approximately 1 day after the formation of the primary sympathetic trunk, some cells separate from this primary trunk and migrate dorsally into the paravertebral region (Kuntz, 1910; Kirby and Gilmore, 1976) . Formation of the definitive sympathetic ganglion occurs as a result of this dorsal cell migration. After the cells arrive at their definitive location, a number of significant developmental changes occur. Considerable cytological maturation occurs in the lumbosacral paravertebral sympathetic ganglia of chick embryos. At E7-8 neuroblasts with large dense core vesicles are prominent. By ElO-12 these neuroblasts have increased in size and the large dense-core vesicles are seen in cellular processes, but they are no longer present in the cytoplasm of the cell body. By E13-15 small dense-core vesicles are observed in the neuroblast population. Some cells with very large dense-core vesicles are observed in the ganglion between E7 to Ell, but they are not evident after El1 (Wechsler and Schmekel, 1967; Luckenbill-Edds and van Horn, 1980) . In addition to these cytological changes, evidence indicates that morphological synapses are present only after the sympathetic ganglia reach their definitive location. Most authors agree that in the lumbosacral paravertebral sympathetic ganglia of the chick, the first synapses are detected at E7-8 (Wechsler and Schmekel, 1967; Ross et al., 1978; Luckenbill-Edds and van Horn, 1980) , although some workers report that they are not numerous until somewhat later (Hruschak et al., 1982) . Taken together, these observations on synapse formation and cytological maturation indicate that considerable maturation occurs in the sympathetic ganglion cell population during E7 to E13. These changes probably occur as a result of a complex series of genetic, cellular, and hormone-mediated events (Landis and Patterson, 1981) . During this period of extensive sympathetic ganglion development, we have observed a dramatic decline in SLI content. Quail sympathetic ganglia from stage 23-24, which corresponds to E8-9 in the chick, contain substantial amounts of SLI. During the next 2 days this SLI content drops precipitously. This decrease is due to an absolute decrement in SLI content in the ganglia, and not just to a relative increase of tissue that does not contain SLI. There are several ways this decrease might occur. One is that some cells may cease to contain SLI, but survive and express other phenotypic characteristics. Such a reduction in intracellular SLI content could be accomplished by several mechanisms, including decreased synthesis, increased catabolism, or increased release of SLI. A second alternative is that some cells which contain SLI may die. A third possibility is that the decrease in SLI content may be due to some modification of the molecular structure of the peptide in the Vol. 4, No. 2, Feb. 1984 25 as tissue that makes it undetectable by the antibodies we have used. A fourth possibility is that the reduction in SLI content in the ganglion is a reflection of increased transport of SLI from the cell bodies to processes and terminals that are excluded from our dissection. Irrespective of the way in which the decline in SLI occurs, its temporal correlation with other developmental events in the ganglion is intriguing. The fact that the decline in SLI content occurs during the period when morphological synapse formation has been detected is consistent with observations that preganglionic nerve activity in uiuo or membrane depolarization in vitro can reduce substance P and SLI content in developmentally older rat superior cervical ganglia (Kessler et al., 1981, Figure 5 . Quantitation of SLI in developing embryonic sympathetic ganglia. Lumbosacral paravertebral sympathetic ganglia were removed from the embryo at the stage indicated, and SLI was quantitated by radioimmunoassay as described under "Materials and 1983a, b; Kessler and Black, 1982) . The ability of quail Cohen, A. M. (1974) 
